Next Level of Hybrid Clinical Trials in Gastroenterology: Ask Us Anything

What’s it about?

Are decentralized clinical trials (DCTs) and hybrid trials just a temporary hype or here to stay? What are their true benefits and who is using them already? 

In this pharma-exclusive session, we'll give you a quick overview about DCTs for gastroenterology and how they work. There will also be plenty of chance to ask our experts any specific questions you may have. 

Exclusive Live Session for Pharma Professionals 
Tuesday, September 20 2022
3 – 3:45 PM CET 
Meet the experts

Join our experts Umberto and Matthias, and ask them any questions you may have. We look forward to seeing you there!

Want to have a free, personalized session just for you? No problem, email us your preferred time, date and topic at hello@climedo.de! 

IMG_6385 (1)

Dr. Matthias Roos

Pharma Sector Lead
Climedo
 
Matthias works as Pharma Sector Lead at Climedo where he focuses on corporate strategies around patient centricity and knowledge building.
 
He previously gained experience in the pharma sector in the field of clinical trials and worked as a management consultant at McKinsey & Company.
 
Matthias has worked as a Postdoc at MIT in the field of protein science and holds a PhD in Physics. In 2017, he won the Ernst Award of the German Chemical Society and became a research fellow of the German National Academy of Sciences Leopoldina. So far, he has published 15 peer-reviewed publications in scientific journals.

Umberto-Rosato

Dr. Umberto Rosato

Clinical Research Associate
TFS – Clinical Contract Research Organization
 
Umberto has been working in clinical and pre-clinical research for more than 10 years. After graduating in Biology, he did his PhD in Oncology at the National Center for Biotechnology in Madrid, and continued his training at the National Cancer Institute in USA, working in Gastroenterology with a focus on liver disease.
 
He then completed a Master in Clinical Research in Italy and is currently working as a Clinical Research Associate, supporting sites in all aspects related to clinical trials.
 
From November this year, Umberto will start the next step of his career as a Clinical Trial Liaison for Miltenyi Biomedicine, a company specializing in CAR-T cell development. His primary duties will be to help sites increase patient enrolment and retention for clinical trials.
What's in it for you?
COMPETITIVE ADVANTAGE

Find out why DCTs for gastroenterology, urology and gynecology matter and how your company can gain a competitive advantage with them.

BENCHMARKING

Learn how other companies are already mastering the power of DCTs, based on a European survey with over 100 respondents.

NETWORKING & DISCUSSION

Talk to other industry professionals in gastroenterology, urology and gynecology and find out how they are tackling challenges similar to yours.

Did you know?

80%

of patients are more likely to participate if they can use mobile technology.

Source: Global Virtual Clinical Trials Markets, 2021-2028

75%

of patients favor mobile trials over traditional ones.

Source: Global Virtual Clinical Trials Markets, 2021-2028

72%

of physicians report better or similar experiences with remote engagement.

Source: Sermo Covid-19 HCP Survey, 2020

Who is Climedo?

CLIMEDO

The Digital Platform for Innovative Clinical Trial Execution.

Our modular and user-friendly EDC solution ("Electronic Data Capture") enables pharmaceutical and medical device companies to efficiently validate their products and medical innovations in a virtual and patient-centric way.

By digitally connecting all parties involved, such as sponsors, doctors and patients, communication and data flow are simplified and accelerated significantly.

Climedo software for decentralized clinical trials